Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Dr. Reddy’s Laboratories Ltd. ( (IN:DRREDDY) ) has provided an update.
Dr. Reddy’s Laboratories has notified stock exchanges that it has made available the official transcript of its earnings call for the quarter ended 31 December 2025, held on 21 January 2026, on the company’s website in accordance with Indian listing regulations. The disclosure, signed by the company secretary and compliance officer, underscores the firm’s ongoing efforts to maintain regulatory compliance and provide transparent, timely communication to investors and other stakeholders regarding its financial performance.
More about Dr. Reddy’s Laboratories Ltd.
Dr. Reddy’s Laboratories Ltd. is a global pharmaceutical company headquartered in Hyderabad, India, engaged in the development, manufacture and marketing of generic medicines, active pharmaceutical ingredients and other healthcare products across key markets including India, the United States and other international geographies.
Average Trading Volume: 105,761
Technical Sentiment Signal: Buy
Current Market Cap: 1030.4B INR
See more insights into DRREDDY stock on TipRanks’ Stock Analysis page.